ArticleSexually transmitted diseases2026
Doxycycline Postexposure Prophylaxis in the Dominican Republic: Investigating Healthcare Provider Knowledge, Attitudes, and Practices in a Caribbean Clinical Setting.
Article in Sexually transmitted diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundDoxycycline postexposure prophylaxis (Doxy-PEP) is effective in preventing bacterial sexually transmitted infections (STIs), yet little is known about contextual factors and barriers influencing its implementation outside of the United States and Europe. In Latin America and the Caribbean, provider knowledge, attitudes, and practices (KAP) regarding Doxy-PEP remain largely unexplored. This study assessed physician perspectives on this prevention tool at a clinic in the Dominican Republic.
methodsBetween June and August 2024, semi-structured interviews were conducted in Spanish with 12 physicians at Clínica de Familia La Romana. Transcripts were translated and analyzed using inductive KAP codes, with deductive coding applied to identify subthemes.
resultsMajor themes included: (1) STI disparities, (2) STI management experiences, (3) Doxy-PEP benefits, (4) Doxy-PEP concerns, (5) Doxy-PEP implementation, and (6) patient selection. Familiarity with Doxy-PEP was limited, with only one provider reporting prior use. Providers attributed rising STI rates to gaps in community knowledge and socioeconomic disparities and mentioned the added local challenges of self-medication and unregulated antibiotic use. Perceived benefits of Doxy-PEP included its preventive potential, affordability, and dosing simplicity. Concerns included potential misuse contributing to antimicrobial resistance, particularly given over-the-counter antibiotic availability. Providers emphasized the need for standardized patient counseling and prescribing guidelines to ensure appropriate and equitable use.
conclusionsProviders view Doxy-PEP as a promising prevention tool, but successful implementation will require uniform guidance and education reflecting the local healthcare context. Provider perspectives are essential to guide responsible rollout in the Dominican Republic and other low- and middle-income settings across the region.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.